Co-founder / Managing Partner
Data Science driven investment fund focused on strategically-timed investments at the inflection point of technological megatrends, investing in the synergetic convergence of specific DeepTech verticals. The fund is internationally renowned for its use of sophisticated analytical systems for investment target identification and due-diligence.
Longevity.Capital is a specialized Longevity Industry Index Hedge Fund with enhanced liquidity that uses hybrid investment technologies to combine the profitability of venture funds with the liquidity of hedge funds, significantly de-risking the interests of LPs and providing the best and most promising Longevity companies with relevant amounts of investment.
A leading Deep Tech analytical agency focused on AI, Longevity, Crypto Economy, and Convergence of Technological MegaTrends.
The mastermind nexus behind the corporate knowledge and intelligence of the Deep Knowledge Group.
Aging Analytics Agency
Aging Analytics Agency is the world’s premier provider of industry analytics on the topics of Longevity, Precision Preventive Medicine and Economics of Aging, and the convergence of technologies such as AI, Blockchain, Digital Health and their impact on the healthcare industry.
Longevity International UK
Head of International Development
Longevity International is a social enterprise bringing together start-ups, industry, academic and governmental stakeholders under one umbrella to provide a unified voice and coordinating vehicle for positive discourse and change to ensure the ‘longevity dividend’ is accessible to everyone. Its first geographic focus is the United Kingdom.
Dmitry is well known for his support of life extension think-tanks in Oxford and Cambridge and many other related non-profit activities. He is the Managing Trustee of the Biogerontology Research Foundation, a UK charity expediting the coming paradigm shift from disease treatment to personalized precision prevention.
Longevity FinTech Company
Founder and Director
Longevity Industry focused UK financial technology company, is aiming to provide White Label AgeTech, Fintech and WealthTech solutions for Financial Institutions to be prepared for the Silver Tsunami Economy and adapt their infrastructure to satisfy needs of the Senior Generation.
AI-Pharma Investment Fund is a hybrid investment fund focused on the AI in Pharma and Drug discovery sectors.The fund structures its portfolio based on sophisticated industry intelligence and comparative analytics provided by the world-leading Longevity Analytics entity Aging Analytics Agency.
Longevity Bank is the first bank to on-board AgeTech, HealthTech, Data Science and AI to meet needs of the Senior Generation and people of all ages by developing new financial products designed for clients who are planning to live extra long lives and want to remain high functioning and financially stable throughout.
Longevity AI Consortium
The Longevity AI Consortium will serve as a leading R&D hub and industry-academic hotspot for advanced AI-driven personalized preventive diagnostics, prognostics and therapeutics. The main concept of precision medicine is providing health care which is individually tailored to a person’s genes, lifestyle and environment
Longevity Swiss Foundation
Longevity Swiss Foundation Engaged with members of the Swiss government in establishing a National Swiss Longevity Development Plan to extend life expectancy through the application of AI, working alongside Swiss financial institutions,making Switzerland a leader in Longevity, Precision Health and Biomedicine
All Party Parliamentary Group for Longevity
Head of International Development of the Secretariat for APPG for Longevity
The All Party Parliamentary Group for Longevity coordinates a cross-disciplinary exchange on the benefits of longevity (as opposed to the ‘problems’ of ageing) within an ethical, citizen-centred framework to maximise the societal benefits of enabling healthier, more productive and purposeful lives.
NeuroTech Analytics specializes in the production of open-access and commercial comparative analytics on the full scope of the global NeuroTech industry, ranging from brain-computer interfaces to implant technologies, neurostimulation and neuromodulation, and neuroplasticity-increasing apps.
Member of the Board
Deep Knowledge Ventures flagship portfolio company. A leading company applying AI and Deep Learning for drug discovery development of biomarkers of aging.